In Vitro hRPTEC TERT1 Model for Uranium‐Induced Nephrotoxicity Pathway Study
Journal of Toxicology · 2026-01 · 2026 (1)
DOI: 10.1155/jt/6692188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Toxicology, online erschienen am 17.06.2026. Verfasst von Marie Frerejacques und 7 weiteren Autor:innen. Beteiligte Einrichtung: LRSI, SESANE, PSE-SANTE, Nuclear Safety and Radiation Protection Authority (ASNR), Fontenay-aux-Roses, 92262, France. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As a heavy metal and alpha emitter, uranium U(VI) presents chemical and radiological toxicity risks. Its toxicity particularly targets the kidneys in the event of intoxication, but the detailed study mechanisms leading to uranium‐induced renal failure have not yet been studied based on the adverse outcome pathway (AOP) approach. Using a well‐specialized in vitro model of renal proximal tubule epithelial cells (hRPTEC TERT1), this research aims to contribute to the development of the AOP of kidney toxicity. After identifying the U(VI) concentrations that induce deleterious effects (apoptosis and necrosis/cytotoxicity), key events linked to oxidative stress, apoptosis, survival, inflammation, and kidney toxicity are studied at the gene and protein levels. Apoptosis (Caspase 3/7 activity) is induced starting from exposure to 300 μM and necrosis (LDH assay) from 500 μM with a rate of 60%. hRPTEC cells have an IC50 of 420 μM after 48 h U(VI) exposure. Uranium induces an early 2‐fold rise in ROS production, and an antioxidant response was observed accordingly. Cell survival signaling appeared to be enhanced at 100 μM, while higher concentrations (> 300 μM) induced a marked inflammatory response, with increased levels of TNFα (6,5‐fold), IL‐6, and IL‐18, leading to a 16% increase in caspase 3/7 at 300 μM and LDH at 500 μM. A slight increase of 22% in the KIM‐1 protein level is observed at 500 μM, and limited changes occurred for other nephrotoxicity biomarkers. In conclusion, this exploratory work generated a multiplex panel detailing the key events in the AOP of uranium‐induced renal failure (Graphical Abstract). This panel features a human phenotype of renal proximal tubule epithelial cells, the preferential target of uranium in the kidney, while also considering the dose‐dependent effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- LRSI, SESANE, PSE-SANTE, Nuclear Safety and Radiation Protection Authority (ASNR), Fontenay-aux-Roses, 92262, France.
- Biochemistry Department, University of Poitiers, INSERM IRMETIST U1313 CHU of Poitiers, Poitiers, 86000, France, univ-poitiers.fr.
ORCID-Profile: Marie Frerejacques, Sebastien Giraud, Céline Bouvier-Capely, Clara Steichen, Yann Guéguen
Zitieren
APA
Frerejacques, M., Powell, V., Giraud, S., Manoury, A., Bouvier-Capely, C., Hauet, T., Steichen, C., & Guéguen, Y. (2026). In Vitro hRPTEC TERT1 Model for Uranium‐Induced Nephrotoxicity Pathway Study. Journal of Toxicology, 2026(1). https://doi.org/10.1155/jt/6692188
Vancouver
Frerejacques M, Powell V, Giraud S, Manoury A, Bouvier-Capely C, Hauet T, et al. In Vitro hRPTEC TERT1 Model for Uranium‐Induced Nephrotoxicity Pathway Study. Journal of Toxicology. 2026;2026(1). doi:10.1155/jt/6692188
BibTeX
@article{Frerejacques2026,
author = {Frerejacques, Marie and Powell, Victoria and Giraud, Sebastien and Manoury, Annabelle and Bouvier-Capely, Céline and Hauet, Thierry and Steichen, Clara and Guéguen, Yann},
title = {In Vitro hRPTEC TERT1 Model for Uranium‐Induced Nephrotoxicity Pathway Study},
journal = {Journal of Toxicology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jt/6692188}
}
EUVIMED